Skip to content

Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors

Development and Evaluation of Comprehensive Care Program for Their Return to Normal Life and Community Among Lung Cancer Survivors

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05078918
Enrollment
800
Registered
2021-10-15
Start date
2021-09-08
Completion date
2025-02-28
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer, Lung Neoplasm

Keywords

Lung Cancer, Survivorship, Quality of Life

Brief summary

The purpose of this study is to develop a comprehensive care program for their return to normal life and community among lung cancer survivors and evaluate the effectiveness of the program.

Detailed description

Lung cancer patients scheduled for curative surgery will be enrolled in this study. The comprehensive care program will be developed, and provided to the intervention group before and after surgery. Outcomes will be assessed 6 months and 1 year after surgery. To evaluate the effectiveness of the program, a control group will be enrolled first and used as a comparator.

Interventions

Comprehensive care program includes education and re-evaluation process. Education using video-materials to help patients adapt to the new normal before and after surgery. And re-evaluation patient's needs 1 month after surgery and arrangement resources.

OTHERUsual care

Usual care includes encouraging deep breathing and exercise using inspirometer, postoperative early ambulation, giving information at discharge and follow up 1 month after surgery.

Sponsors

Ministry of Science and ICT, Republic of Korea
CollaboratorOTHER_GOV
Samsung Medical Center
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

This is a non-randomized controlled trial. Control groups will be enrolled first considering contamination of educational intervention.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with non-small cell lung cancer(NSCLC) and scheduled for curative resection. * NSCLC with clinical stage Ⅰ-Ⅲ * Patients who understood the study and gave written informed consent.

Exclusion criteria

* Recurred lung cancer * Patients with extra-pulmonary synchronous double primary cancer. * Patients with history of other cancer diagnosis or treatment in the last 3 years. Drop Criteria: * When surgery was canceled or pathologic stage IV was confirmed after surgery. * When the tumor was not found to be non-small cell lung cancer, including benign tumor, after surgery * Withdrawal informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Mental adjustment to cancer at 6 months after surgery6 months after surgeryThe Mini-Mental Adjustment to Cancer (Mini-MAC) scale, a short form instrument derived from the MAC and designed to measure coping with cancer. The scale consists of 29 items and 5 sub-dimensions as follows: Fighting spirit, helplessness/hopelessness, anxious preoccupation, fatalism and cognitive avoidance. The mini-MAC is a Likert type scale with four response options: (1) definitely does not apply to me (2) does not apply to me (3) applies to me (4) definitely applies to me.

Secondary

MeasureTime frameDescription
Lung cancer specific symptomsBefore surgery (baseline) and 1, 6, 12 months after surgeryThe symptoms are assessed by the European Organization for Research Treatment of Cancer Quality of Life Questionnaire lung cancer module 13 (EORTC QLQ-LC13). The scale for symptom is transformed into a score from 0 to 100, derived by 4-point Likert scale. Higher scores mean a more burden of disease.
Dyspnea (mMRC)Before surgery (baseline) and 1, 6, 12 months after surgeryDyspnea is measured by the modified Medical Research Council Dyspnea Scale (mMRC). The mMRC scales grade 0 to grade 4, based on the severity of dyspnea.
Dyspnea (CAT)Before surgery (baseline) and 1, 6, 12 months after surgeryDyspnea is also measured by COPD Assessment Test (CAT). Range of CAT scores from 0-40. Higher scores denote a more severe impact of COPD on a patient's life.
Unmet NeedsBefore surgery (baseline) and 1, 6, 12 months after surgeryUnmet needs are assessed by the Cancer Survivors' Unmet Needs (CaSUN). There are 5 domains; existential survivorship (14-item), Comprehensive Cancer Care (6-item), Information (3-item), Quality of Life (2-item), Relationships (3-item). It assesses the unmet needs and strength of needs. In this study, only the information domain is investigated.
Quality of life (EORTC QLQ-C30)Before surgery (baseline) and 1, 6, 12 months after surgeryThe quality of life is assessed by the European Organization for Research Treatment of Cancer Quality of Life Questionnaire core30 (EORTC QLQ-C30). The scale for quality of life is transformed into a score from 0 to 100, derived by 4-point Likert scale. Higher scores represent a better quality of life.
Physical ActivityBefore surgery (baseline) and 1, 6, 12 months after surgeryPhysical activity is assessed by International Physical Activity Questionnaire-7 (IPAQ-7). This questionnaire measures duration (minutes) and frequency (days) of physical activity in the last 7 days.
Mental adjustment to cancerBefore surgery (baseline) and 12 months after surgeryThe Mini-Mental Adjustment to Cancer (Mini-MAC) scale, a short form instrument derived from the MAC and designed to measure coping with cancer. The scale consists of 29 items and 5 sub-dimensions as follows: Fighting spirit, helplessness/hopelessness, anxious preoccupation, fatalism and cognitive avoidance. The mini-MAC is a Likert type scale with four response options: (1) definitely does not apply to me (2) does not apply to me (3) applies to me (4) definitely applies to me.
DistressBefore surgery (baseline) and 1, 6, 12 months after surgeryNCCN Distress Thermometer & Problem List
Anxiety and depressionBefore surgery (baseline) and 6, 12 months after surgeryAnxiety and depression are assessed by the Hospital Anxiety and Depression Scale (HADS). The HADS is a 14-item instrument that reflects two dimensions; depression (seven items) and anxiety (seven items). Each item is rated on a 4-point scale from 0 to 3, with a maximum of 21 for anxiety and depression.

Countries

South Korea

Contacts

Primary ContactDong Wook Shin, MD., Ph.D.
dongwook.shin@samsung.com82-2-3410-1062
Backup ContactGenehee Lee, APN., M.S.N.
genehee.lee@samsung.com82-2-3410-1062

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026